As more and more organizations undertake digitalization and innovation initiatives, they are turning to the chief data officer (CDO) to help them fully leverage those investments. While the role still is evolving, its broad outlines are clear.
Fundamental changes in the marketplace for medicines, as well as the rapid and continuing evolution of technology are bringing new challenges and opportunities for life sciences companies and their contribution to healthcare systems.
Rapid advancements in technology resulting in our entire modern way of life comes with attendant issues and risks, such as cybercrime. No single entity – whether they be nations, corporations or individuals – is immune.
The role of the chief information security offi cer (CISO) has changed dramatically in the last decade. No longer merely a digital sheriff called on to protect the fi rm’s data valuables, the CISO is expected to act as a full strategic partner with the rest of the C-suite.
In February 2015, President Obama, speaking at a White House Summit on cybersecurity and consumer protection, declared that the Internet has become a sort of Wild West, where private corporations are prime targets of hackers and cyber criminals.